Media ReleasesNext Science

View All Next Science News

Next Science - XPERIENCE study findings released

Study finds Infection Prevention Benefit in Periprosthetic Joint Surgery for XPERIENCE™ ADVANCED SURGICAL IRRIGATION


  • Dr. Robert Harris MD has released the findings of a retrospective study which examined infection rates up to 90 days post Primary Joint Arthroplasties across Hip (THA), Knee (TKA) and Shoulder (TSA) surgery.
  • Patient cohort of 423 exhibited 0% infection rate up to 90 days post-surgery, compares favourably with typical incidence rates.
  • The retrospective analysis found XPERIENCE™ to be efficacious and warranted further investigation as a sole anti-microbial irrigant to determine potential utility in reducing the overall burden of Periprosthetic Joint Infection (PJI) and improved patient outcomes.
  • Study findings are the first of a series of independent retrospective studies examining the impact of XPERIENCE™ to reduce surgical site infection rates. 

Sydney Australia Friday, 3 November 2023: Next Science Limited (ASX: NXS) (Next Science or Company), a medical technology company focused on commercialising its proprietary XBIO™ suite of products to reduce the impact of biofilm-based infections in human health, is pleased to announce the presentation of a study into preventing periprosthetic joint infection (PJI) across hip (THA), knee (TKA) and shoulder (TSA) primary surgeries. 

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?